Understanding the role of LH: Myths and facts

Reproductive BioMedicine Online

Volumn 15, Issue 4, 2007, Pages 468-477

  Fischer, Robert ^a   Baird, David ^b   Bosch, Ernesto ^c   Hugues, Jean Noël ^d   Humaidan, Peter ^e   Ludwig, Michael ^f   Shoham, Zeev ^g   Westergaard, Lars ^h  

^a Fertility Center Hamburg   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^d HÔPITAL JEAN VERDIER   (France)

^e VIBORG HOSPITAL   (Denmark)

^f ENDOKRINOLOGIKUM HAMBURG   (Germany)

^g KAPLAN MEDICAL CENTER   (Israel)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Folliculogenesis; Gonadotrophin; Gonadotrophin releasing hormone analogue; Luteinizing hormone

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

AGE; CLINICAL PRACTICE; CONFERENCE PAPER; CONTINUING EDUCATION; DRUG DOSE COMPARISON; ESTROGEN SYNTHESIS; FERTILIZATION; FERTILIZATION IN VITRO; GERMANY; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MENSTRUAL CYCLE; NONHUMAN; OOCYTE MATURATION; OVARY FOLLICLE DEVELOPMENT; OVULATION; OVULATION INDUCTION; PREDICTION; PREGNANCY; TREATMENT FAILURE;

EID: 35148901628     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60375-6     Document Type: Conference Paper

References (79)

1. Ajzen I, Fishbein M 1977 Attitude-behaviour relations: a theoretical analysis and review of empirical research. Psychological Bulletin 84, 888-918.
2. Andersen AN, Devroey P, Arce JC 2006 Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Human Reproduction 21, 3217-3227.
3. Baird DT 1987 A model for follicular selection and ovulation: lessons from superovulation. Journal of Steroid Biochemistry 27, 15-23.
4. Balasch J, Fabregues F, Penarrubia J et al. 2006 Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Human Reproduction 21, 1884-1893.
5. Balasch J, Vidai E, Penarrubia J et al. 2001 Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Human Reproduction 16, 1636-1643.
6. Baruffi RL, Mauri AL, Petersen CG et al. 2007 Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis. Reproductive BioMedicine Online 14, 14-25.
7. Berger MJ, Taymor ML 1971 The role of luteinizing hormone in human follicular maturation and function. American Journal of Obstetrics and Gynecology 111, 708-710.
8. Bjercke S, Fedorcsak P, Abyholm T et al. 2005 IVF/ICS1 outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression. Human Reproduction 20, 2441-2447.
9. Bosch E, Pau E, Albert C et al. 2006 Impact of different amounts of LH in controlled ovarian hyperstimulation oocyte donation cycles. Fertility and Sterility 86 (Suppl. 2, abstract book), S425.
10. Burgues S 2001 The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Human Reproduction 16, 2525-2532.
11. Chappel SC, Howles C 1991 Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Human Reproduction 6, 1206-1212.
12. Conway GS, Honour JW, Jacobs HS 1989 Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clinical Endocrinology (Oxford) 30, 459-470.
13. Couzinet B, Lestrat N, Brailly S et al. 1988 Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. Journal of Clinical Endocrinology and Metabolism 66, 552-556.
14. Davison SL, Bell R, Donath S et al. 2005 Androgen levels in adult females: changes with age, menopause, and oophorectomy. Journal of Clinical Endocrinology and Metabolism 90, 3847-3853.
15. De Placido G, Alviggi C, Perino A et al. 2005 Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Human Reproduction 20, 390-396.
16. De Placido G, Alviggi C, Mollo A et al. 2004 Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clinical Endocrinology (Oxford) 60, 637-643.
17. De Placido G, Mollo A, Alviggi C et al. 2001 Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Human Reproduction 16, 1875-1879.
18. De Placido G, Alviggi C, Mollo A et al. 2000 Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone. Human Reproduction 15, 17-20.
19. Esposito MA, Barnhart KT, Coutifaris C et al. 2001 Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertility and Sterility 75, 519-524.
20. European Recombinant Human LH Study Group 1998 Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. Journal of Clinical Endocrinology and Metabolism 83, 1507-1514.
21. Fabregues F, Creus M, Penarrubia J et al. 2006 Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertility and Sterility 85, 925-931.
22. Fanchin R, Peltier E, Frydman R et al. 2001 Human chorionic gonadotropin: does it affect human endometrial morphology in vivo? Seminars in Reproductive Medicine 19, 31-35.
23. Ferraretti AP, Gianaroli L, Magli MC et al. 2004 Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertility and Sterility 82, 1521-1526.
24. Fevold HL 1941 Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology 28, 33-36.
25. Filicori M, Cognigni GE, Tabarelli C et al. 2002 Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. Journal of Clinical Endocrinology and Metabolism 87, 1156-1161.
26. Fleming R, on behalf of the Luveris Pre-treatment Group, Durnerin IC et al. 2006 Pre-treatment with r-hLH: respective effects on antral follicular count and ovarian response to r-hFSH. Human Reproduction 21 (Suppl. 1, abstract book), i54.
27. Fleming R, Rehka P, Deshpande N et al. 2000 Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Human Reproduction 15, 1440-1445.
28. Fleming R, Lloyd F, Herbert M et al. 1998 Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Human Reproduction 13, 1788-1792.
29. Fleming R, Chung CC, Yates RW et al. 1996 Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Human Reproduction 11, 1854-1858.
30. Garcia-Velasco JA, Moreno L, Pacheco A et al. 2005 The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertility and Sterility 84, 82-87.
31. Greep RO, Van Dyke HB, Chow BF 1942 Gonadotropin of swine pituitary: various biological effects of purified thylkentrin (FSH) and pure matakentrin (ICSH). Endocrinology 30, 635-649.
32. Hillier SG 1994 Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Human Reproduction 9, 188-191.
33. Hillier SG, Miro F 1993 Local regulation of primate granulosa cell aromatase activity. Journal of Steroid Biochemistry and Molecular Biology 44, 435-439.
34. Homburg R, Weissglas L, Goldman J 1988 Improved treatment for anovulation in polycystic ovarian disease utilizing the effect of progesterone on the inappropriate gonadotrophin release and clomiphene response. Human Reproduction 3, 285-288.
35. Howles CM, Macnamee MC, Edwards RG et al. 1986 Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet 2, 521-522.
36. Hugues JN, Soussis J, Calderon I et al. 2005 Does the addition of recombinant LH in WHO group II anovulatory women overresponding to FSH treatment reduce the number of developing follicles? A dose-finding study. Human Reproduction 20, 629-635.
37. Huhtaniemi I, Jiang M, Nilsson C et al. 1999 Mutations and polymorphisms in gonadotropin genes. Molecular and Cellular Endocrinology 151, 89-94.
38. Humaidan P, Bungum M, Bungum L et al. 2004 Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reproductive BioMedicine Online 8, 635-643.
39. Humaidan P, Bungum L, Bungum M et al. 2002 Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist downregulation and recombinant FSH stimulation. Human Reproduction 17, 2016-2021.
40. Hurwitz JM, Santoro N 2004 Inhibins, activins, and follistatin in the aging female and male. Seminars in Reproductive Medicine 22, 209-217.
41. Jiang M, Pakarinen P, Zhang FP et al. 1999 A common polymorphic allele of the human luteinizing hormone beta-subunit gene: additional mutations and differential function of the promoter sequence. Human Molecular Genetics 8, 2037-2046.
42. Klein NA, Battaglia DE, Fujimoto VY et al. 1996 Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. Journal of Clinical Endocrinology and Metabolism 81, 1038-1045.
43. Kolibianakis EM, Kalogeropoulou L, Griesinger G et al. 2007 Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Human Reproduction Update, doi: 10.1093/humupd/dmm008 e-pub ahead of print, http://humupd.oxfordjournals.org/cgi/content/abstract/dmm008v1 [accessed 15 August 2007].
44. Kolibianakis EM, Zikopoulos K, Schiettecatte J et al. 2004 Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Human Reproduction 19, 2490-2496.
45. Lisi F, Rinaldi L, Fishel S et al. 2002 Use of recombinant LH in a group of unselected IVF patients. Reproductive BioMedicine Online 5, 104-108.
46. Lisi F, Rinaldi L, Fishel S et al. 2001 Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reproductive BioMedicine Online 3, 190-194.
47. Lossl K, Andersen AN, Loft A et al. 2006 Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols. Human Reproduction 21, 2593-2600.
48. Loumaye E, Engrand P, Shoham Z et al. 2003 Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Human Reproduction 18, 314-322.
49. Mannaerts B, de Loeuw R, Geelen J et al. 1991 Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology 129, 2623-2630.
50. Marrama P, Montanini V, Celani MF et al. 1984 Decrease in luteinizing hormone biological activity/immunoreactivity ratio in elderly men. Maturitas 5, 223-231.
51. Marrs R, Meldrum D, Muasher S et al. 2004 Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reproductive BioMedicine Online 8, 175-182.
52. Merviel P, Antoine JM, Mathieu E et al. 2004 Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer. Fertility and Sterility 82, 119-125.
53. Mitchell R, Hollis S, Rothwell C et al. 1995 Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive. Clinical Endocrinology (Oxford) 42, 501-507.
54. Mochtar M, Ziech M, van Wely M 2007 Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews CD005070.
55. Nyboe Andersen A, Humaidan P, Fried G et al. 2006 Addition of rLH (Luveris) to rFSH during the final days of follicular maturation in IVF/ ICSI treated patients. A Nordic randomized multicenter trial. Human Reproduction 21 (suppl. 1, abstract book), i54.
56. O'Dea L and the US Recombinant Human LH Study Group 2000 Recombinant LH in support of recombinant FSH in female hypogonadotropic hypogonadism - evidence of threshold effect. Fertility and Sterility 74 (Suppl. 1), S36.
57. Out HJ, Mannaerts BM, Driessen SG et al. 1995 A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Human Reproduction 10, 2534-2540.
58. Overes HW, de Leeuw R, Kloosterboer HJ 1992 Regulation of aromatase activity in FSH-primed rat granulosa cells in vitro by follicle-stimulating hormone and various amounts of human chorionic gonadotrophin. Human Reproduction 7, 191-196.
59. Piltonen T, Koivunen R, Ruokonen A et al. 2003 Ovarian age-related responsiveness to human chorionic gonadotropin. Journal of Clinical Endocrinology and Metabolism 88, 3327-3332.
60. Punnonen R, Ashorn R, Vilja P et al. 1988 Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. Fertility and Sterility 49, 479-482.
61. Regan L, Owen EJ, Jacobs HS 1990 Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 336, 1141-1144.
62. Ropelato MG, Garcia-Rudaz MC, Castro-Fernandez C et al. 1999 A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 84, 4629-4636.
63. Ruvolo G, Bosco L, Pane A et al. 2007 Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertility and Sterility 87, 542-546.
64. Schoot DC, Harlin J, Shoham Z et al. 1994 Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Human Reproduction 9, 1237-1242.
65. Shoham Z, Mannaerts B, Insler V et al. 1993 Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertility and Sterility 59, 738-742.
66. Shoham Z, Balen A, Patel A et al. 1991 Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertility and Sterility 56, 1048-1053.
67. Soules MR, Sherman S, Parrott E et al. 2001 Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertility and Sterility 76, 874-878.
68. Stanger JD, Yovich JL 1985 Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. British Journal of Obstetrics and Gynaecology 92, 385-393.
69. Tesarik J, Mendoza C 2002 Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Human Reproduction 17, 3129-3137.
70. van Wely M, Westergaard LG, Bossuyt PM et al. 2003 Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis. Fertility and Sterility 80, 1086-1093.
71. Vendola KA, Zhou J, Adesanya OO et al. 1998 Androgens stimulate early stages of follicular growth in the primate ovary. Journal of Clinical Investigation 101, 2622-2629.
72. Vihko KK, Kujansuu E, Morsky P et al. 1996 Gonadotropins and gonadotropin receptors during the perimenopause. European Journal of Endocrinology/European Federation of Endocrine Societies 134, 357-361.
73. Welt CK, Jimenez Y, Sluss PM et al. 2006 Control of estradiol secretion in reproductive ageing. Human Reproduction 21, 2189-2193.
74. Westergaard LG, Erb K, Laursen SB et al. 2001 Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective study. Fertility and Sterility 76, 543-549.
75. Westergaard LG, Laursen S, Andersen CY 2000 Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotropic women undergoing assisted reproduction. Human Reproduction 15, 1003-1008.
76. Westergaard LG, Wiberg N, Andersen CY et al. 1998 Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles. Human Reproduction 13, 2612-2619.
77. Westergaard LG, Erb K, Laursen S et al. 1996 The effect of human menopausal gnnadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Human Reproduction 11, 1209-1213.
78. Yong EL, Baird DT, Yates R et al. 1992 Hormonal regulation of the growth and steroidogenic function of human granulosa cells. Journal of Clinical Endocrinology and Metabolism 74, 842-849.
79. Zumoff B, Strain GW, Miller LK et al. 1995 Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. Journal of Clinical Endocrinology and Metabolism 80, 1429-1430.